Dr. Sandra Fryhofer on lifting of J&J vaccine pause | COVID-19 Update for April 26, 2021

Dr. Sandra Fryhofer, the AMA liaison to the CDC’s Advisory Committee on Immunization Practices (ACIP), discusses the committee's recommendation to lift the pause on the Johnson & Johnson vaccine and what physicians need to know to help address patients' concerns.

0:00 AMA COVID-19 Update for April 26, 2021
0:45 Details about ACIP's recommendation to lift J&J pause at last Friday's meeting
1:58 Is it a surprise that the ACIP committee vote was not unanimous? (10 voted in favor, 4 against, with one abstention)
3:00 How much detail is in the amended emergency use authorization statement from the FDA?
5:00 Have there been more cases reported? Can you review the chain of events?
7:17 Were they able to identify any other risk factors that might pre-dispose someone to developing TTS?
8:29 Does TTS seem to be a class effect of viral vector vaccines?
9:23 Have they seen TTS with other vaccines authorized here in the U.S.?
10:54 Doesn’t covid increase the risk of blood clots?
12:32 Talk more about the effectiveness of Janssen vaccine
14:50 Why is having J&J vaccine so important?
16:26 Share final thoughts